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Type C, and D toxins produced by Clostridium botulinum caused ADP-ribosylation of a protein of 24 kDa 
in membrane preparations of rat clonal pheochromocytoma cells (PC12) and of proteins of 25 and 26 kDa 
in neuron-rich culture of fetal rat brain cells. The ADP-ribosylation reaction was dependent on the presence 
of MgCh, GTP and GTPyS. The results obtained suggested that the ADP-ribosylation reaction is responsi- 
ble for the development of the biological activity of the botulinurn neurotoxins and that the target of this 
reaction may be novel GTP-binding proteins localized on cell membranes. 
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1. INTRODUCTION 
The ADP-ribosylation reaction has been shown 
to play important roles in pathological changes in- 
duced by various bacterial toxins on eukaryotic cell 
[l-5]. Extensive analysis of this reaction revealed 
the presence of specific nucleotide-binding pro- 
teins as the substrates which are involved in the 
mechanisms of important cellular functions: Diph- 
theria toxin catalyses the ADP-ribosylation of 
elongation factor-2, which results in inhibition of 
protein synthesis [l]. Cholera toxin and pertussis 
toxins ADP-ribosylate GTP-binding proteins, G,, 
Gi (regulatory components in adenylate cyclase 
system) [2,3], and Gt (regulatory component of 
photoreception system) [4]. Recently, botulinum 
binary toxin (CZ toxin) was found to ADP- 
ribosylate non-muscle actin [5]. These observa- 
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tions encouraged us to examine whether botulinum 
neurotoxins have the ability to catalyse ADP- 
ribosylation. 
Botulinum neurotoxins which are classified into 
seven immunologically distinct types (A, B, Cl, D, 
E, F, G) have been shown to inhibit irreversibly the 
spontaneous and evoked release of acetylcholine 
at peripheral synapses [6,7]. More recently, 
botulinum neurotoxin type Cr was shown to 
possess neuron-specific cytotoxic activity in 
cultures of fetal rat brain cells [8]. Although the 
binding properties of botulinurn neurotoxins to 
synaptosomal membranes have been reported [9], 
the intracellular mechanism of the actions of 
botulinum neurotoxin remains unknown. Here, we 
describe the ability of botulinurn neurotoxin type 
Cr and D to ADP-ribosylate specific proteins of 
24-26 kDa in membrane preparations of cells of 
neural origin. The dependence of the ADP- 
ribosylation reaction on MgClz and guanine 
nucleotide suggests the possibility that the 
24-26 kDa proteins are novel GTP-binding pro- 
teins . 
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2. MATERIALS AND METHODS 
2.1. Chemicals 
Dulbecco’s modified Eagles medium, fetal calf 
serum and horse serum were purchased from Gib- 
co (NY). [adenylate-32P]Nicotinamide adenine di- 
nucleotide (NAD) (spec. act. 990 Ci/mmol) was 
purchased from New England Nuclear. Other 
chemicals used were of reagent grade. 
2.2. Toxins 
Botulinum type Ci and D toxins were purified 
from culture media of C. botulinurn type C strain 
Stockholm and type .D strain South Africa as 
described in [lo]. Botulinurn type A toxin was pur- 
chased from Wako (Tokyo) and purified as in [ 111. 
Botulinurn type C progenitor toxins (C-L and C-M 
from strain CB19), D progenitor toxins (D-L and 
from strain CB16) [12] and purified botulinum CZ 
were kindly donated by Dr I. Ohishi (Osaka). 
2.3. Cell culture 
Clonal rat pheochromocytoma cells (PC12) were 
cultured as described [13] in Dulbecco’s modified 
Eagles medium supplemented with 5% fetal calf 
serum, 5% horse serum, 100 U/ml penicillin and 
100 pg/ml streptomycin. Dissociated cells of em- 
bryonic (16th day) brain of Wistar rats were 
prepared and cultured as in [8] using the same 
medium as for PC12 cells. The brain cells were 
treated with 10 PM cytosine ,&D-arabinofurano- 
side from the 4th day in culture for 24 h to sup- 
press multiplication of glial cells and harvested on 
the 8th day in culture. 
2.4. Preparation of cell homogenates and 
membranes 
Pelleted cells (500-1000 pg protein) were lysed 
by addition of 500~1 of 10 mM Na-Pi, pH 7.4, 
and sonicated for 30 s at 0°C to obtain cell homo- 
genates for 90 min at 100000 x g. The cell mem- 
branes were washed by repeating the centrifuga- 
tion and suspended in 10 mM Na-Pi solution 
(pH 7.4) containing 20 mM KC1 and 1 mM phe- 
nylmethylsulfonyl fluoride, 
2.5. Assay of ADP-ribosylation 
ADP-ribosylation was carried out in a reaction 
mixture containing 10 mM thymidine, 2 mM 
EDTA, 2 mM dithiothreitol, 2pM [32P]NAD 
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(0.5-l &i/tube) and 20 mM Hepes-NaOH 
(pH 7.4). Protein amounts of toxin and cell sample 
used are indicated in the figure legends. The in- 
cubation was performed at 37°C in a total volume 
of 40 ~1. After the indicated time the reaction was 
terminated by the addition of 20 ~1 of 1% SDS and 
boiling for 2 min. 
2.6. SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (12% 
gel) was performed according to Laemmli [ 141. 
The following molecular mass markers were used: 
,&galactosidase (116 kDa), phosphorylase b 
(97.4 kDa), bovine serum albumin (66 kDa), 
ovalbumin (45 kDa), carbonic anhydrase (29 
kDa), soybean trypsin inhibitor (20.1 kDa), and cy- 
lactalbumin (14.2 kDa). Samples were alkylated 
with N-ethylmaleimide prior to electrophoresis as 
described in [15]. Gels were stained with 
Coomassie brillant blue R-250 and subjected to 
autoradiography. 
3. RESULTS AND DISCUSSION 
Homogenates of PC12 cells were incubated with 
[32P]NAD and 4 mM MgClz in the presence of 
various types of botulinum neurotoxins and 
botulinurn CZ toxin to examine their ability to 
catalyse ADP-ribosylation. As shown in fig. 1, type 
Cr , D and type C progenitor toxin (C-M) 
specifically labeled a single protein band of 
24 kDa. Type A toxin which is the most potent 
botulinurn neurotoxin failed to label this protein 
band. Botulinurn CZ toxin which has been shown 
to ADP-ribosylate nonmuscle actin of 45 kDa also 
failed to label the band of 24 kDa. Therefore, the 
possibility that the labeling of the 24 kDa band is 
due to CZ toxin contaminating in the samples of the 
neurotoxins was excluded. Type D toxin-catalyzed 
ADP-ribosylation of the 24 kDa protein was also 
found in the membrane preparation of PC12 cells 
(fig.2, lanes 4,5) indicating that this protein sub- 
strate is localized on the membrane. When a mem- 
brane preparation of neuron-rich fetal rat brain 
cells was incubated with [32P]NAD in the presence 
of type D toxin, radioactivities were incorporated 
into two protein bands with closely related 
molecular masses, 25 and 26 kDa (fig.2, lanes 6,7) 
slightly above the band of PC12 cells with similar 
intensities. Type D toxin-catalyzed ADP- 
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Fig.1. ADP-ribosylation of homogenates of PC12 cells 
by several botulinum toxins. PC12 cell homogenates 
(30ag protein) were incubated without (lanes 1,9) or 
with 0.1 pg botulinum type A toxin (lane 2), type Cr tox- 
in (lane 3), type D toxin (lane 4), type C-L progenitor 
toxin (lane 5), type C-M progenitor toxin (lane 6), type 
D-L progenitor toxin (lane 7), type D-M progenitor tox- 
in (lane 8), and botulinum type CZ toxin (lane 10) in the 
presence of [32P]NAD (990 Ci/mmol, about 1 &i) and 
4 mM MgCl2 for 30 min at 37°C as described in section 
2. The autoradiogram of the SDS-polyacrylamide gel of 
the labeled proteins is shown. The arrow denotes the 
position of the ADP-risobylation substrate of 24 kDa. 
ribosylation of a membrane preparation of C6 
glioma cells was also found in the protein band of 
24 kDa (fig.2, lanes 8,9), but the intensity of the 
When PC12 membranes were incubated with 
[32P]NAD in the presence of type D toxin for 
incorporated radioactivities was very weak. 
various times, labeling of the 24 kDa protein was 
observed at incubation time longer than 20 min 
(fig.3, lanes l-5). Type D toxin-catalyzed ADP- 
ribosylation of the 24 kDa protein was abolished 
by monoclonal antibody designated as CA12 
which recognizes the heavy chain of type Cr and D 
toxins and inhibits the binding of these toxins to 
synaptosomal membrane [9,16]. Together with the 
knowledge on other bacterial toxins which bind to 
plasma membranes by their heavy chain and 
release the activated light chain possessing ADP- 
ribosyltransferase activity toward intracellular 
targets, it is anticipated that the light chain of 
botulinum neurotoxin has a similar enzymatic 
function. The above results also suggest hat the 
botulinum neurotoxin types Ci and D which bind 
Fig.2. Comparison of molecular masses of ADP- 
ribosylation substrates in membranes from different cell 
sources of rat. Membrane preparations of PC12 cells 
(70 pg protein; lanes 1,4,5), neuron-rich fetal brain cells 
(50 fig protein; lanes 2,6,7) and C6 cells (50 pg protein; 
lanes 3,8,9) were incubated without (lanes l-3) or with 
0.5 gg botulinum type D toxin (lanes 4-9) in the presence 
of 2pM [32P]NAD (about 2,&i) and 4 mM MgCl2 for 
30 min at 37°C. The reaction mixtures corresponding to 
lanes 5, 7 and 9 contained 20pM GTP. 
to neuronal membrane by their heavy chain under- 
go an activation process corresponding to the lag 
The effects of divalent cations and nucleotides 
time required for the exertion of the ADP-ribosyl- 
on the type D toxin-catalyzed ADP-ribosyltrans- 
ferase activity in membrane preparations of PC12 
transferase activity by their light chain. 
(fig.4A) and fetal brain cells (fig.4B) were exam- 
ined. In the absence of both MgCl2 and 
nucleotides, no ADP-ribosyltransferase activity 
was found in both membrane preparations (fig.4, 
lanes 3). Addition of 4 mM MgClz alone greatly 
stimulated the toxin-catalyzed ADP-ribosylation 
of the 24 kDa protein in membranes of PC12 
(fig.4A, lane 7) and 25, 26 kDa doublet proteins in 
fetal brain cells (fig.4B, lane 7). CaClz at 4 mM 
also stimulated the ADP-ribosylation (fig.3, lane 
6). However, the combination of 4 mM MgCl2 and 
4 mM CaClz rather abolished the ADP- 
ribosylation (fig.3, lane 7). Although the addition 
of 20 /IM ATP had no effect (fig.4, lanes 4), 20 ,uM 
of either GTP or GTP$S, (a nonhydrolyzable 
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Fig.3. Time course of the toxin-catalyzed ADP- 
ribosylation reaction and the effect of monoclonal anti- 
toxin-antibody. Membrane preparations of PC12 cells 
(120 ,~g protein) were incubated with 0.6 pg botulinum 
type D toxin and 2 PM [32P]NAD (about 1 &i) in the 
presence of 4 mM MgClr (lanes l-5,8), 4 mM CaCl2 
(lane 6), or 4 mM MgCl2 and 4 mM CaCl2 (lane 7) for 
5 (lane I), 10 (lane 2), 20 (lane 3), 30 (lanes 4,6-8) or 
60 min (lane 5) at 37°C. The arrow indicates the position 
of 24 kDa. 
analog of GTP) alone stimulated the ADP- 
ribosylation of 24-26 kDa substrate (fig.4, lanes 
5,6) to a lesser extent than that by 4 mM MgClz. 
In contrast, in the presence of 4 mM MgCl2, 
GTPyS greatly diminished the ADP-ribosylation 
of 24-26 kDa substrates (fig.4, lanes lo), although 
ATP and GTP had little effect on the ADP- 
ribosylation in the presence of MgCl2 (fig.4, lanes 
8,9). The ADP-ribosylation catalyzed by type Cr 
toxin also showed a similar dependence on MgCl2 
and guanine nucleotides (not shown). 
GTPyS-dependent inhibition of bacterial toxin- 
catalyzed ADP-ribosylation is a property 
characteristic to the GTP-binding proteins, G, and 
Gi [17]. Therefore, it is strongly suggested that the 
substrate for the type Cr and D toxin-catalyzed 
ADP-ribosylation is a GTP-binding protein itself 
or a component involved in the GTP-dependent 
regulatory system. The difference in molecular 
mass of botulinum neurotoxin-substrate between 
PC 12 cells (24 kDa) and neuron-rich fetal rat brain 
cells (25 and 26 kDa) suggests that this protein ex- 
ists in different tissues as different subtypes. Fur- 
thermore, the incorporation of radioactivity from 
[32P]NAD with much higher intensity into PC12 
cells and neuron-rich brain cells than in C6 glioma 
cells suggests that the 24-26 kDa protein substrates 
are involved in secretion and transmitter release. 
Recently, it was reported that a 21 kDa membrane 
protein of bovine adrenal grand serves as the sub- 
strate for the botulinum type D toxin-catalyzed 
ADP-ribosylation [ 181. However, the characteris- 
tics of this 21 kDa protein as a GTP-binding pro- 
Fig.4. Effects of MgCl2 and nucleotides on the ADP- 
ribosylation of the 24-26 kDa substrates. Membrane 
preparations of PC12 cells (A, 260,~g protein) or 
neuron-rich culture of fetal rat brain cells (B, 24Opg 
protein) were incubated without (lanes 1,2) or with 
0.5 ag botulinum type D toxin (lanes 3-10) in the 
absence (lanes 1,3-6) or presence of 4 mM MgCl2 (lanes 
2,7-10) for 30 min at 37°C. The reaction mixtures con- 
tained the following nucleotides; 20 pM ATP (lanes 3,7), 
20pM GTP (lanes 4,8), 20pM GTPrS (lanes 5,lO). The 
reaction mixtures also contained 2 PM [32P]NAD (about 
1 &i). 
tein are not yet known and its molecular mass is 
lower than that which we found in the present 
study. Recently, a novel GTP-binding protein of 
24 kDa has been purified to homogeneity from pig 
brain membranes (Katada, T., personal com- 
munication). A collaborative work to examine 
whether the purified 24 kDa GTP-binding protein 
serves as the substrate for the ADP-ribosyltrans- 
ferase activity of botulinum neurotoxin is currently 
underway. 
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